Zydus receives USFDA approval for glaucoma, altitude sickness drug

Pharma/BioPharma |  News | 0 Comment | 18 Jan, 2019

Zydus Cadila has received the final approval from the USFDA to market Acetazolamide ER Capsules (US RLD – Diamox). It will be manufactured at the group’s formulations manufactur...Read more

Regulatory submission of Tafamidis by Pfizer accepted by USFDA

Pharma/BioPharma |  News | 0 Comment | 17 Jan, 2019

Pfizer has announced that the US Food and Drug Administration (FDA) accepted for filing the company’s New Drug Applications (NDAs) for tafamidis for the treatment of transthyretin amy...Read more

Organisational change at AstraZeneca to drive innovation

Pharma/BioPharma |  News | 0 Comment | 14 Jan, 2019

AstraZeneca has recently announced organisational changes to support continued scientific innovation and commercial success in the main therapy areas as the Company enters a new phase in it...Read more

Hetero launches Generic Lapatinib in India

Pharma/BioPharma |  News | 0 Comment | 11 Jan, 2019

Hetero, one of India’s leading generic pharmaceutical companies and world’s largest producer of anti-retroviral drugs, has announced the launch of generic version of Lapatinib (...Read more

analytica Anacon India, India Lab Expo gearing up for 2019

Pharma/BioPharma |  News | 0 Comment | 10 Jan, 2019

With more than 9,500 visitors, analytica Anacon India, India Lab Expo 2018 and PHARMA Pro&Pack Expo had smashed all the records. With 9,641 visitors and 261exhibitors, analytica Anacon...Read more

SEG101 therapy by Novartis gets FDA approval

Pharma/BioPharma |  News | 0 Comment | 09 Jan, 2019

Novartis has announced that the US Food and Drug Administration has granted crizanlizumab (SEG101) Breakthrough Therapy designation for the prevention of vaso-occlusive crises (VOCs) in pat...Read more

Sanofi, Regeneron reform global Immuno-Oncology Partnership

Pharma/BioPharma |  News | 0 Comment | 08 Jan, 2019

Sanofi and Regeneron Pharmaceuticals, Inc. have restructured their global Immuno-oncology Discovery and Development Agreement for new immunooncology cancer treatments. The 2015 Agreement wa...Read more

NaMuscla from Lupin receives EC Approval

Pharma/BioPharma |  News | 0 Comment | 08 Jan, 2019

Lupin has announced that the European Commission has approved NaMuscla® (mexiletine) for the symptomatic treatment of myotonia in adults with non-dystrophic myotonic (NDM) disorders. N...Read more

Vyome raises $22M to advance dermatology pipeline

Pharma/BioPharma |  News | 0 Comment | 07 Jan, 2019

Vyome Therapeutics Inc, a clinical-stage specialty pharmaceutical company developing novel medicines for treating skin diseases caused by resistant microbes has announced the closing of a $...Read more

Lupin Pharma issues voluntary recall of Ceftriaxone for Injection

Pharma/BioPharma |  News | 0 Comment | 07 Jan, 2019

Lupin Pharmaceuticals is voluntarily recalling 5 lots of Ceftriaxone for Injection, USP, 250mg, 10 lots of Ceftriaxone for Injection, USP, 500mg, 24 lots of Ceftriaxone for Injection, USP, ...Read more

Lupin receives FDA approval for Lurasidone Hydrochloride Tablets

Pharma/BioPharma |  News | 0 Comment | 07 Jan, 2019

Pharma major Lupin has announced that it has received approval for its Lurasidone Hydrochloride Tablets, 20 mg, 40 mg, 60 mg, 80 mg & 120 mg from the United States Food and Drug Adminis...Read more

India Pharma 2019 & India Medical Device 2019 to be held in Bengaluru

Pharma/BioPharma |  News | 0 Comment | 03 Jan, 2019

The Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers, along with Federation of Indian Chambers of Commerce & Industry (FICCI), is organising the ...Read more

Ocular Therapeutix Announces Completion of Debt Refinancing

Pharma/BioPharma |  News | 0 Comment | 01 Jan, 2019

Ocular Therapeutix, a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announce...Read more

SCHOTT KAISHA brings new portfolio of highly customizable prefillable glass syringes to India

Pharma/BioPharma |  News | 0 Comment | 28 Dec, 2018

Leading pharmaceutical packaging company, SCHOTT KAISHA has launched a highly specialized glass syringe portfolio in India, that further minimizes the risk of drug/container interactions fo...Read more

ICRA assigns stable outlook for Indian Pharma companies

Pharma/BioPharma |  News | 0 Comment | 27 Dec, 2018

ICRA has given a stable outlook on the Indian pharmaceutical industry. The headwinds from pricing pressure in large regulated markets, especially USA, increased cost related to regulatory c...Read more

Dr. Reddy's launches Aspirin and Extended-Release Dipyridamole Capsules

Pharma/BioPharma |  News | 0 Comment | 27 Dec, 2018

Dr. Reddy’s has announced the launch of Aspirin and Extended-Release Dipyridamole Capsules, a therapeutic equivalent generic version of Aggrenox (aspirin and extended-release dipyrida...Read more

Lupin announce partnership with AbbVie

Pharma/BioPharma |  News | 0 Comment | 24 Dec, 2018

Pharma major Lupin Limited (Lupin) and global biopharmaceutical company AbbVie Inc., has announced that AbbVie has licensed Lupin’s MALT1 (Mucosa-Associated Lymphoid Tissue Lymphoma T...Read more

Holistic quality enhancement is the need of the hour: 70th Indian Pharmaceutical Congress

Pharma/BioPharma |  News | 0 Comment | 24 Dec, 2018

With the aim of sharing best practices to aid the domestic industry become a world leader by 2030, the three-day 70thIndian Pharmaceutical Congress was organized at the Amity University Cam...Read more